Obermatt
See Similar Stocks →

Nuvectis Pharma

NAQ:NVCT · US67080T1088
BiotechnologySmall

360° View

no current rank
Price/Sales—
Price/Earnings—
Price/Book91
Dividend Yield1
Revenue Growth—
Profit Growth57
Capital Growth19
TSR 52w20
Leverage22
Liquidity—
Refinancing29
Combined—
Analyst Opinions25
Pro Holdings17
Opinion Changes50
Market Pulse53

Profile

CountryUSA
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Founded2020
Employees2
Websitenuvectis.com
ISINUS67080T1088
Last UpdateApr 2, 2026
Index & Theme
OncologyBiopharmaHealth CarePharmaceutical

Description

Nuvectis Pharma, Inc. operates as a clinical-stage biopharmaceutical company. The company focuses on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology. The company seeks to dev…

Similar Stocks

The companies this stock is ranked against.

Compare Nuvectis Pharma with its peers
Monte Rosa Therapeutics
NSQ:GLUE
13
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Tyra Biosciences
NSQ:TYRA
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Kyverna Therapeutics
NSQ:KYTX
6
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Surrozen
NAQ:SRZN
33
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Gilead
NSQ:GILD
67
CountryUSA
IndustryBiotechnology
SizeXX-Large
Full Stock Analysis →
Celcuity
NAQ:CELC
96
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →